Cargando…
Modulating gene expression in breast cancer via DNA secondary structure and the CRISPR toolbox
Breast cancer is the most commonly diagnosed malignancy in women, and while the survival prognosis of patients with early-stage, non-metastatic disease is ∼75%, recurrence poses a significant risk and advanced and/or metastatic breast cancer is incurable. A distinctive feature of advanced breast can...
Autores principales: | Kretzmann, Jessica A, Irving, Kelly L, Smith, Nicole M, Evans, Cameron W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693572/ https://www.ncbi.nlm.nih.gov/pubmed/34988459 http://dx.doi.org/10.1093/narcan/zcab048 |
Ejemplares similares
-
The conservation physiology toolbox: status and opportunities
por: Madliger, Christine L, et al.
Publicado: (2018) -
Chemical biology: a toolbox to unlock neurochemical epigenetics?
por: Özcelik, Dennis
Publicado: (2020) -
CRISPR–Cas9 gRNA efficiency prediction: an overview of predictive tools and the role of deep learning
por: Konstantakos, Vasileios, et al.
Publicado: (2022) -
How Good is the Science That Informs Government Policy? A Lesson From the U.K.’s Response to 2020 CoV-2 Outbreak
por: Cooper, Jessica, et al.
Publicado: (2021) -
The continuously evolving CRISPR barcoding toolbox
por: Gaj, Thomas, et al.
Publicado: (2018)